Skip to main content

Phenotypic and Genotypic Characterization of Thermophilic Campylobacter Isolated from Chicken in Côte d’Ivoire | Chapter 9 | Theory and Applications of Microbiology and Biotechnology Vol. 3


Thermophilic Campylobacters are major causes of gastroenteritis in human. The main risk factor of infection is consumption of contaminated or by cross-contaminated poultry meat. In Coteˆ d’Ivoire, gastroenteritis is usually observed but no case of human campylobacteriosis has been formally reported to date. The aims of this study were to determine prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from chickens ceaca in commercial slaughter in Abidjan. Between May and November 2009, one hundred and nineteen (119) chicken caeca samples were collected and analyzed by passive filtration method followed by molecular identification (PCR). From these 119 samples, 76 (63.8%) were positive to Campylobacter tests. Among the positive colonies, 51.3% were C. jejuni and 48.7% were C. coli. Of the 39 C. jejuni isolates, 79.5%, 38.5%, 17.9%, 10.3%, and 7.7% were, respectively, resistant, to nalidixic acid, ciprofloxacin, amoxicillin, erythromycin, and gentamicin. Among the 37 isolates of C. coli, 78.4%, 43.2%, 13.5%, 8.1%, and 0% were resistant, respectively, to the same antibiotics. On the other hand, detection of virulence putative gene shows presence of cadF in 100 % of tested strains. In addition, cdtA, cdtB and cdtC genes were detected in 100%; 69.43% and 71.06% respectively of C. jejuni isolates. Moreover, only cdtA gene of cdt genes was detected in 12.82% of C. coli strains tested in this study. In conclusion, we reported in this study the presence of high Campylobacter contamination of the studied chickens. Molecular identification of the bacteria was performed and determination of high resistance to antimicrobials of the fluoroquinolone family was revealed.  

Author(s) Details

Dr. Goualié Gblossi Bernadette
Laboratoire  de Biotechnologies, Agriculture et Valorisation des Ressources  Biologiques, Unité de Formation et de Recherche en Biosciences, Université de Cocody-Abidjan, 01 BP 582, Abidjan, Cote d’Ivoire.

Dr. Akpa Eric Essoh
Laboratoire  de Biotechnologies, Agriculture et Valorisation des Ressources  Biologiques, Unité de Formation et de Recherche en Biosciences, Université de Cocody-Abidjan, 01 BP 582, Abidjan, Cote d’Ivoire.

Dr. Kakou-N’Gazoa Elise Solange
Institut Pasteur de Côte d’Ivoire, 01 BP 490, Abidjan, Cote d’Ivoire.

Dr. Guessennd Natalie
Institut Pasteur de Côte d’Ivoire, 01 BP 490, Abidjan, Cote d’Ivoire

Dr. Bakayoko Souleymane
Institut Pasteur de Côte d’Ivoire, 01 BP 490, Abidjan, Cote d’Ivoire.

 Prof. Niamké Lamine Sébastien
Laboratoire  de Biotechnologies, Agriculture et Valorisation des Ressources  Biologiques, Unité de Formation et de Recherche en Biosciences, Université de Cocody-Abidjan, 01 BP 582, Abidjan, Cote d’Ivoire.

Prof. Dosso Mireille
Institut Pasteur de Côte d’Ivoire, 01 BP 490, Abidjan, Cote d’Ivoire.

View Book: - http://bp.bookpi.org/index.php/bpi/catalog/book/154

Comments

Popular posts from this blog

A Prospective Study about Safety and Efficacy of Perioperative Lidocaine Infusion | Chapter 09 | New Horizons in Medicine and Medical Research Vol. 8

 Opioids cause clinically significant side effects such as respiratory depression, immunosuppression, muscle rigidity, negative inotropism, nausea, vomiting, hyperalgesia, urine retention, postoperative ileus, and drowsiness. Perioperative opioids are a major contributor to the United States' and other countries' opioid epidemics. Non-opioid analgesics, particularly lidocaine, are becoming more common for perioperative use as a result of this. A total of 185 adult patients were randomly assigned to one of two groups: control group I (105 patients) [fentanyl group] or group ii (80 patients) [opioid-free anaesthesia group]. Lidocaine 1.5 mg/kg bolus followed by 1.5 mg/kg/h infusion intraoperatively, and 1.5-2 mg/kg/h infusion for 2-8 hours postoperatively were given to patients in both groups at anaesthetic induction. Intraoperatively, both groups received analgesic adjuvants such as diclofenac 75 mg, paracetamol 1 gm, and mgso4 30-50 mg/kg. If the mean arterial pressure (map)

A Brief Study of Middleware Technologies: Programming Applications and Management Systems | Chapter 15 | Novel Research Aspects in Mathematical and Computer Science Vol. 1

  Many platforms, services, applications, hardware, and operating systems are connected through the middleware layer. Because the middleware layer abstracts much low-level complexity and makes applications and software systems portable, it allows disparate systems to interface and function together in harmony. Middleware technologies enable software engineers to swiftly construct software systems and applications, allowing developers to focus on more important tasks. This chapter examines several types of middleware systems and discusses middleware capabilities, middleware operation, middleware's function in cloud-based systems, and the best middleware platforms to use. Middleware systems are widely utilised and can be found in practically any software system or application. Middleware programmes provide as a link between many sorts of systems and protocols. They serve as a mechanism for various systems. To successfully exchange information, it runs on a variety of operating system

Patients’ Perspective of Acute Post-operative Pain Management: A Multicentre Survey of Tertiary Hospitals in Maharashtra, India | Chapter 08 | New Horizons in Medicine and Medical Research Vol. 8

 When postoperative pain is adequately controlled, patients' satisfaction and patient-related outcomes (PROs) increase. Understanding the patients' perspective is crucial since it supports in the formulation of improvement strategies. Because wrong attitudes and assumptions might block pain alleviation, patients' attitudes and beliefs are critical. As a result, a multicenter study of patients' attitudes, beliefs, experiences, and satisfaction levels with acute postoperative pain management was done in Maharashtra's tertiary hospitals. In addition, the responses were examined to evaluate if the Acute Pain Service (APS) resulted in improved patient outcomes and satisfaction. A 13-item questionnaire adapted from previous studies was used to capture patients' experiences with postoperative pain treatment. The responses of 179 patients are included in the study. The findings revealed that 91.6 percent of patients experienced postoperative pain, with 75.5 percent